Overview

Improving Treatment Outcomes in Pharmacotherapy of Generalized Social Anxiety Disorder

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
This study will compare the effectiveness of either adding clonazepam or placebo to standard treatment or switching to venlafaxine in treating generalized social anxiety disorder in individuals who have not responded to treatment with sertraline.
Phase:
Phase 4
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Clonazepam
Sertraline
Venlafaxine Hydrochloride